Prolia

Do you want to link to this Other Site and leave Amgen.co.kr?

YOU ARE NOW LEAVING AMGEN KOREA'S WEB SITE. Amgen Korea takes takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Prolia® Pre-filled Syringe 

  • Product Name (Korean) 프롤리아® 프리필드시린지(데노수맙)
  • Product Name (English) Prolia® Pre-filled Syringe(denosumab)
  • Active Ingredient (Korean) 데노수맙
  • Active Ingredient (English) denosumab
  • API content 60 mg/1 mL
  • Excipients Sorbitol, glacial acetic acid, polysorbate 20, sodium hydroxide, water for injection, injection needle
  • Treatment Treatment of osteoporosis.
  • Indications
    1. Treatment of postmenopausal women with osteoporosis.
    2. Treatment to increase bone mass in men with osteoporosis.
    3. Treatment of Glucocorticoid-Induced Osteoporosis
    4. Treatment of bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.
    5. Treatment of bone loss in women receiving adjuvant aromatase inhibitor therapy for breast cancer.
  • Prolia® Product information